Behavioral and psychological symptoms (BPSD) are now known to be frequently associated to cognitive and functional decline in Alzheimer‘s disease and related disorders. They are present since the early stages of the disease and have negative impact on the disease process. BPSD assessment is crucial in clinical practice and also in future clinical trials targeting disease-modifying therapies for dementia. In this article, we will first review current assessment tools for BPSD, mainly global and domain-specific scales, and new assessment methods, currently available or in development, including new scales, diagnostic criteria and new technologies such as ambulatory actigraphy.
References
[1]
Robert, P.H.; Verhey, F.R.; Byrne, E.J.; Hurt, C.; De Deyn, P.P.; Nobili, F.; Riello, R.; Rodriguez, G.; Frisoni, G.B.; Tsolaki, M.; Kyriazopoulou, N.; Bullock, R.; Burns, A.; Vellas, B. Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium. Eur. Psychiatry？2005, 20, 490–496, doi:10.1016/j.eurpsy.2004.09.031. 16310680
[2]
Steinberg, M.; Shao, H.; Zandi, P.; Lyketsos, C.G.; Welsh-Bohmer, K.A.; Norton, M.C.; Breitner, J.C.; Steffens, D.C.; Tschanz, J.T. Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study. Int. J. Geriatr. Psychiatry？2008, 23, 170–177, doi:10.1002/gps.1858. 17607801
[3]
Perrault, A.; Oremus, M.; Demers, L.; Vida, S.; Wolfson, C. Review of outcome measurement instruments in Alzheimer's disease drug trials: psychometric properties of behavior and mood scales. J. Geriatr. Psychiatry Neuro.？2000, 13, 181–196, doi:10.1177/089198870001300403.
[4]
Forester, B.P.; Oxman, T.E. Measures to Assess the Noncognitive Symptoms of Dementia in the Primary Care Setting. Prim. Care Companion J. Clin. Psychiatry？2003, 5, 158–163, doi:10.4088/PCC.v05n0403. 15213777
[5]
Cummings, J.L. The Neuropsychiatric Inventory: Assessing psychopathology in dementia patients. Neurology？1997, 48 (Suppl. 6), S10–S16. 9153155
[6]
Ownby, R.L.; Koss, E.; Smyth, K.A.; Whitehouse, P.J. The factor structure of the Brief Psychiatric Rating Scale in Alzheimer's disease. J. Geriatr. Psychiatry Neurol.？1994, 7, 245–250, doi:10.1177/089198879400700410. 7826495
[7]
Mack, J.L.; Patterson, M.B. The evaluation of behavioral disturbances in Alzheimer's disease: the utility of three rating scales. J. Geriatr. Psychiatry Neurol.？1994, 7, 99–115, doi:10.1177/089198879400700206. 8204195
[8]
Rosen, W.G.; Mohs, R.C.; Davis, K.L. A new rating scale for Alzheimer's disease. Am. J. Psychiatry？1984, 141, 1356–1364. 6496779
Harwood, D.G.; Ownby, R.L.; Barker, W.W.; Duara, R. The behavioral pathology in Alzheimer's Disease Scale (BEHAVE-AD): factor structure among community-dwelling Alzheimer's disease patients. Int. J. Geriatr. Psychiatry？1998, 13, 793–800, doi:10.1002/(SICI)1099-1166(1998110)13:11<793::AID-GPS875>3.0.CO;2-Q. 9850876
[11]
Raskin, A.; Crook, T. Relative's Assessment of Global Symptomatology (RAGS). Psychopharmacol. Bull.？1988, 24, 7597–7763.
[12]
Patterson, M.B.; Mack, J.L.; Mackell, J.A.; Thomas, R.; Tariot, P.; Weiner, M.; Whitehouse, P.J. A longitudinal study of behavioral pathology across five levels of dementia severity in Alzheimer's disease: the CERAD Behavior Rating Scale for Dementia. The Alzheimer's Disease Cooperative Study. Alzheimer Dis. Assoc. Disord.？1997, 11 (Suppl. 2)., S40–S44, doi:10.1097/00002093-199700112-00006. 9236951
[13]
Baumgarten, M.; Becker, R.; Gauthier, S. Validity and reliability of the dementia behavior disturbance scale. J. Am. Geriatr. Soc.？1990, 38, 221–226. 2313003
[14]
Robert, P.; Verhey, F.R.J.; Aalten, P.; Cortes, F.; Byrne, E.J. Neuropsychiatric outcome for clinical trials. J. Nutr. Health Aging？2007, 11, 345–347. 17653496
[15]
Aalten, P.; Verhey, F.R.; Boziki, M.; Bullock, R.; Byrne, E.J.; Camus, V.; Caputo, M.; Collins, D.; De Deyn, P.P.; Elina, K.; Frisoni, G.; Girtler, N.; Holmes, C.; Hurt, C.; Marriott, A.; Mecocci, P.; Nobili, F.; Ousset, P.J.; Reynish, E.; Salmon, E.; Tsolaki, M.; Vellas, B.; Robert, P.H. Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: part I. Dement. Geriatr. Cogn. Disord.？2007, 24, 457–463, doi:10.1159/000110738. 17986816
[16]
Connor, D.J.; Sabbagh, M.N.; Cummings, J.L. Comment on administration and scoring of the Neuropsychiatric Inventory in clinical trials. Alzheimers Dement.？2008, 4, 390–394, doi:10.1016/j.jalz.2008.09.002. 19012863
Kertesz, A.; Davidson, W.; Fox, H. Frontal behavioral inventory: diagnostic criteria for frontal lobe dementia. Can. J. Neurol. Sci.？1997, 24, 29–36. 9043744
[19]
Cohen-Mansfield, J. Conceptualization of agitation: results based on the Cohen-Mansfield Agitation Inventory and the Agitation Behavior Mapping Instrument. Int. Psychogeriatr.？1996, 8 (Suppl. 3), 309–354. 309–315; discussion, 351–354. 9154580
[20]
Alexopoulos, G.S.; Abrams, R.C.; Young, R.C.; Shamoian, C.A. Cornell scale for depression in dementia. Biological Psychiatry？1988, 23, 271–284, doi:10.1016/0006-3223(88)90038-8. 3337862
[21]
Yesavage, J.A.; Brink, T.L.; Rose, T.L. Development and validation of a geriatric depression scale: a preliminary report. J. Psychiatry Res.？1983, 17, 37–49.
[22]
Marin, R.S.; Biedrzycki, R.C.; Firinciogullari, S. Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res.？1991, 38, 143–162, doi:10.1016/0165-1781(91)90040-V. 1754629
[23]
Starkstein, S.E.; Mayberg, H.S.; Preziosi, T.J.; Andrezejewski, P.; Leiguarda, R.; Robinson, R.G. Reliability, validity and clinical correlates of apathy in Parkinsons's disease. J. Neuropsychiatry Clin. Neurosci.？1992, 4, 134–139. 1627973
[24]
Robert, P.H.; Clairet, S.; Benoit, M.; Koutaich, J.; Bertogliati, C.; Tible, O.; Caci, H.; Borg, M.; Brocker, P.; Bedoucha, P. The Apathy Inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment. Int. J. Geriatr. Psych.？2002, 17, 1099–1105, doi:10.1002/gps.755.
[25]
Sockeel, P.; Dujardin, K.; Devos, D.; Denève, C.; Destée, A.; Defebvre, L. The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson's Disease. J. Neurol. Neurosur. Psychiatry？2006, 77, 579–584, doi:10.1136/jnnp.2005.075929.
[26]
De Medeiros, K.; Robert, P.; Gauthier, S.; Politis, A.; Stella, F.; Leotskakos, J.; Taragano, F.; Kremer, J.; Brugnolo, A.; Porteinsson, A.; Geda, Y.; Brodaty, H.; Lyketsos, C. The NPI-C: A clinician-rated Assessment of Neuropsychiatric Symptoms in Dementia. In IPA International Congress, Montreal, QC Canada, 1–5 September 2009.
[27]
Jeste, D.V.; Finkel, S.I. Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome. Am. J. Geriatr. Psychiatry ？2000, 8, 29–34, doi:10.1097/00019442-200002000-00004. 10648292
Robert, P.; Onyike, C.U.; Leentjens, A.F.; Dujardin, K.; Aalten, P.; Starkstein, S.; Verhey, F.R.; Yessavage, J.; Clement, J.P.; Drapier, D.; Bayle, F.; Benoit, M.; Boyer, P.; Lorca, P.M.; Thibaut, F.; Gauthier, S.; Grossberg, G.; Vellas, B.; Byrne, J. Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders. Eur. Psychiatry？2009, 24, 98–104. 19201579
[30]
Mulin, E.; Leone, E.; Dujardin, K.; Delliaux, M.; Leentjens, A.F.; Nobili, F.; Dessi, B.; Tible, O.; Aguera-Ortiz, L.; Osorio, R.; Yesavage, J.; Verhey, F.; Blanc, O.; Llorca, P.; Robert, P. Diagnostic cirteria for apathy in clinical practice. Int. J. Geriatr. Psychiatry？2010. in submission.
[31]
Kupfer, D.J.; Detre, T.P.; Foster, G.; Tucker, G.J.; Delgado, J. The application of Delgado's telemetric mobility recorder for human studies. Behav. Biol.？1972, 7, 585–590, doi:10.1016/S0091-6773(72)80220-7. 5050143
[32]
McPartland, R.J.; Foster, F.G.; Kupfer, D.J.; Weiss, B.L. Activity sensors for use in psychiatric evaluation. IEEE Trans. Biomed. Eng.？1976, 23, 175–178. 1248847
[33]
Ancoli-Israel, S.; Clopton, P.; Klauber, M.R.; Fell, R.; Mason, W. Use of wrist activity for monitoring sleep/wake in demented nursing-home patients. Sleep？1997, 20, 24–27. 9130330
[34]
Yesavage, J.A.; Friedman, L.; Kraemer, H.C.; Noda, A.; Wicks, D.; Bliwise, D.L.; Sheikh, J.; Tinklenberg, J.; Zarcone, V. A follow-up study of actigraphic measures in home-residing Alzheimer's disease patients. J. Geriatr. Psychiatry Neurol.？1998, 11, 7–10, doi:10.1177/089198879801100103. 9686746
[35]
Dane, A.V.; Schachar, R.J.; Tannock, R. Does actigraphy differentiate ADHD subtypes in a clinical research setting? J. Am. Acad. Child Adolesc. Psychiatry？2000, 39, 752–760, doi:10.1097/00004583-200006000-00014. 10846310
[36]
Kemlink, D.; Pretl, M.; Sonka, K.; Nevsimalova, S. A comparison of polysomnographic and actigraphic evaluation of periodic limbmovements in sleep. Neurol. Res.？2007, 30, 234–238. 17767810
[37]
Sadeh, A.; Hauri, P.J.; Kripke, D.F.; Lavie, P. The role of actigraphy in the evaluation of sleep disorders. Sleep？1995, 18, 288–302. 7618029
Nagels, G.; Engelborghs, S.; Vloeberghs, E.; Van Dam, D.; Pickut, B.A.; De Deyn, P.P. Actigraphic measurement of agitated behaviour in dementia. Int. J. Geriatr. Psychiatry？2006, 21, 388–393, doi:10.1002/gps.1483. 16534768
[40]
Mahlberg, R.; Walther, S. Actigraphy in agitated patients with dementia: Monitoring treatment outcomes. Z. Gerontol Geriatr.？2007, 40, 178–184, doi:10.1007/s00391-007-0420-z. 17565435
[41]
Mahlberg, R.; Walther, S.; Eichmann, U.; Tracik, F.; Kunz, D. Effects of rivastigmine on actigraphically monitored motor activity in severe agitation related to Alzheimer's disease: a placebo-controlled pilot study. Arch. Gerontol. Geriatr.？2007, 45, 19–26, doi:10.1016/j.archger.2006.07.006. 16963137
[42]
Volkers, A.C.; Tulen, J.H.; Duivenvoorden, H.J.; Gieteling, M.J.; Wegewijs-De Jong, M.; Van Den Broek, W.W.; Passchier, J.; Pepplinkhuizen, L. Effect of personality dimensions on the diurnal pattern of motor activity. J. Pers.？2002, 70, 233–247, doi:10.1111/1467-6494.05004. 11911121
[43]
Volkers, A.C.; Tulen, J.H.; Van Den Broek, W.W.; Bruijn, J.A.; Passchier, J.; Pepplinkhuizen, L. 24-Hour motor activity after treatment with imipramine or fluvoxamine in major depressive disorder. Eur. Neuropsychopharmacol.？2002, 12, 273–278. 12126865
[44]
Volkers, A.C.; Tulen, J.H.; van den Broek, W.W.; Bruijn, J.A.; Passchier, J.; Pepplinkhuizen, L. Motor activity and autonomic cardiac functioning in major depressive disorder. J. Affect Disord.？2003, 76, 23–30, doi:10.1016/S0165-0327(02)00066-6. 12943930
[45]
Muller, U.; Czymmek, J.; Thone-Otto, A.; Von Cramon, D.Y. Reduced daytime activity in patients with acquired brain damage and apathy: a study with ambulatory actigraphy. Brain Inj.？2006, 20, 157–160, doi:10.1080/02699050500443467. 16421064
[46]
David, R.; Rivet, A.; Robert, P.H.; Mailland, V.; Friedman, L.; Zeitzer, J.M.; Yesavage, J. Ambulatory Actigraphy correlates with apathy in Mild Alzheimer's disease. Dementia？2009. in press.
[47]
Robert, P.H.; Clairet, S.; Benoit, M.; Koutaich, J.; Bertogliati, C.; Tible, O.; Caci, H.; Borg, M.; Brocker, P.; Bedoucha, P. The apathy inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment. Int. J. Geriatr. Psychiatry？2002, 17, 1099–1105, doi:10.1002/gps.755. 12461757
[48]
David, R.; Mulin, E.; Robert, P. Actigraphic assessment of apathy in Alzheimer’s disease. World J. Biol. Psychiatry？2009, 10 (Suppl. 1), 42–43.
[49]
Banerjee, S.; Steenkeste, F.; Couturier, P.; Debray, M.; Franco, A. Telesurveillance of elderly patients by use of passive infra-red sensors in a 'smart' room. J. Telemed. Telecare？2003, 9, 23–29, doi:10.1258/135763303321159657. 12641889
[50]
David, R.; Colazzo, G.; Siccardi, L.; Forcellino, L.; Vada, A.; Louchart, S.; Serrati, C.; Piva, M.; Robert, P. Evaluation of apathy using attentional reaction test in neurodegenerative diseases. Eur. Psychiat.？2008, 23 (Suppl. 2)., 193.
[51]
Shoval, N.; Auslander, G.K.; Freytag, T.; Landau, R.; Oswald, F.; Seidl, U.; Wahl, H.W.; Werner, S.; Heinik, J. The use of advanced tracking technologies for the analysis of mobility in Alzheimer's disease and related cognitive diseases. BMC Geriatr.？2008, 8, 7, doi:10.1186/1471-2318-8-7. 18366748
[52]
Sink, K.M.; Holden, K.F.; Yaffe, K. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA？2005, 293, 596–608, doi:10.1001/jama.293.5.596. 15687315
[53]
Ancoli-Israel, S.; Amatniek, J.; Ascher, S.; Sadik, K.; Ramaswamy, K. Effects of galantamine versus donepezil on sleep in patients with mild to moderate Alzheimer disease and their caregivers: a double-blind, head-to-head, randomized pilot study. Alzheimer Dis. Assoc. Disord.？2005, 19, 240–245, doi:10.1097/01.wad.0000189052.48688.36. 16327351
[54]
Mahlberg, R.; Kunz, D.; Sutej, I.; Kuhl, K.P.; Hellweg, R. Melatonin treatment of day-night rhythm disturbances and sundowning in Alzheimer disease: an open-label pilot study using actigraphy. J. Clin. Psychopharmacol.？2004, 24, 456–459. 15232344
[55]
Singer, C.; Tractenberg, R.E.; Kaye, J.; Schafer, K.; Gamst, A.; Grundman, M.; Thomas, R.; Thal, L.J. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. Sleep？2003, 26, 893–901. 14655926
[56]
Gehrman, P.R.; Connor, D.J.; Martin, J.L.; Shochat, T.; Corey-Bloom, J.; Ancoli-Israel, S. Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease. Am. J. Geriatr. Psychiatry？2009, 17, 166–169, doi:10.1097/JGP.0b013e318187de18. 19155748
